Lung Cancer.pdf

116 W.R. Smythe
Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project:
overall design and findings from baseline screening. Lancet 1999;354:99–105.
Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection
of extrathoracic metastases in patients presumed to have operable non-small
cell lung cancer. Thorax 1994;49:14–19.
Ishida T, Yano T, Maeda K, et al. Strategy for lymphadenectomy in lung cancer
three centimeters or less in diameter. Ann Thorac Surg 1990;50:708–713.
Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves
survival in patients with stages II and IIIa non-small cell lung cancer. Eastern
Cooperative Oncology Group. Ann Thorac Surg 2000;70:358–365.
London L, Baldwin-Ragavan L, de Gruchy J. Revision of the Helsinki Declaration—ethical
standards at risk? S Afr Med J 1999;89:812–813.
Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary
tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;
109:120–129.
Maruyama R, Sugio K, Mitsudomi T, et al. Relationship between early recurrence
and micrometastases in the lymph nodes of patients with stage I non-small-cell
lung cancer. J Thorac Cardiovasc Surg 1997;114:535–543.
Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable
non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients.
Radiother Oncol 1997;42:31–36.
Mountain CF. Revisions in the international system for staging lung cancer. Chest
1997;111:1710–1717.
Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma
based on the new international staging system. J Thorac Cardiovasc Surg
1988;96:440– 447.
Nesbitt JC, Putnam JB Jr, Walsh GL, et al. Survival in early-stage non-small cell
lung cancer. Ann Thorac Surg 1995;60:466– 472.
Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small
cell lung cancer: a meta-analysis using updated data on individual patients
from 52 randomized trials. BMJ 1995;311:899–909.
Passlick B, Kubuschok B, Izbicki JR, et al. Isolated tumor cells in bone marrow predict
reduced survival in node-negative non-small cell lung cancer. Ann Thorac
Surg 1999;68:2053–2058.
Patz EF, Rossi S, Harpole DH, et al. Correlation of tumor size and survival in patients
with stage IA non-small cell lung cancer. Chest 2000;117:1568–1571.
Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of nonsmall-cell
lung cancer with positron-emission tomography. N Engl J Med
2000;343:254–261.
Pisters KMW, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery
for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg
2000;119:429– 439.
Rosell R, Gomez-Condina J, Camps C, et al. A randomized trial comparing preoperative
chemotherapy plus surgery with surgery alone in patients with nonsmall-cell
lung cancer. N Engl J Med 1994;330:153–158.
Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in
a randomized trial comparing perioperative chemotherapy and surgery with
surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer
1998;21:1–6.